A new strategy for melanoma treatment: an investigation of the clinical value of the combination of immune checkpoint inhibitors and oncolytic viruses.

Cancer Cell Int · 2025 · PMC12825276 · PMID 41454366

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Notably, both primary and treated (≥ 1 prior therapy) patients showed a positive trend in outcome and survival prognosis.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.